Stock To Watch: NeoGenomics, Inc. (NASDAQ:NEO)


The leading market experts have placed a mean price target of $10.17 on NeoGenomics, Inc. (NASDAQ:NEO) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.03 a share for the upcoming quarter and $0.10 for the current fiscal. Technical View The technical analysis of NeoGenomics, Inc. plainly substantiates that the 50-day moving average of NeoGenomics, Inc. is $8.47, and stock is hovering 0.45 or +5.32% distant from $8.47. It is noted that the 200-day MA is $7.39, and NeoGenomics, Inc. stock is $1.53 or +20.74% off from this point. NeoGenomics, Inc. (NASDAQ:NEO) 52-week high is $9.23 and the 52-week low is $5.26. This explains if the stock moves $-0.31, it will post a 52-week high. In event of $+69.58% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of NeoGenomics, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, NeoGenomics, Inc. (NASDAQ:NEO) ratio came in at N/A. The stock last ended the trading session at $8.92 and registered a market cap of $687.88M. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. NeoGenomics, Inc. (NASDAQ:NEO) PEG ratio is at 3.72.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)